CURE PHARMA HOLDING CORP COM's ticker is CURR and the CUSIP is 23127P104. A total of 1 filers reported holding CURE PHARMA HOLDING CORP COM in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $16,125 | -23.2% | 150,000 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $21,000 | +5.4% | 150,000 | +18.1% | 0.00% | 0.0% |
| Q4 2022 | $19,933 | -39.6% | 127,000 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $33,000 | 0.0% | 127,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $33,000 | +22.2% | 127,000 | +24.5% | 0.00% | +100.0% |
| Q1 2022 | $27,000 | -27.0% | 102,000 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $37,000 | -50.0% | 102,000 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $74,000 | +34.5% | 102,000 | -4.7% | 0.01% | +50.0% |
| Q2 2021 | $55,000 | -26.7% | 107,000 | +30.5% | 0.00% | -33.3% |
| Q1 2021 | $75,000 | +257.1% | 82,000 | +412.5% | 0.01% | +200.0% |
| Q4 2020 | $21,000 | +50.0% | 16,000 | +60.0% | 0.00% | +100.0% |
| Q3 2020 | $14,000 | -22.2% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $18,000 | -14.3% | 10,000 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $21,000 | -30.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $30,000 | -25.0% | 10,000 | 0.0% | 0.00% | -40.0% |
| Q3 2019 | $40,000 | -23.1% | 10,000 | 0.0% | 0.01% | -28.6% |
| Q2 2019 | $52,000 | +18.2% | 10,000 | 0.0% | 0.01% | +16.7% |
| Q1 2019 | $44,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sandhill Capital Partners LLC | 10,000 | $52,000 | 0.01% |